LEPTIN AND OBESITY – NEUROENDOCRINE , METABOLIC AND ATHEROGENIC EFFECTS OF LEPTIN

od Mišo Šabovič, Alenka Mavri
Izdano 2003-01-01

Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry.

od Nina Vene, Alenka Mavri, Mirjam Gubenšek, Gregor Tratar, Tjaša Vižintin Cuderman, Maja Pohar Perme, Aleš Blinc
Izdano 2016-01-01